Allarity Therapeutics Inc (ALLR) — Cash Flow-to-Debt Ratio
Allarity Therapeutics Inc (ALLR) has a Cash Flow-to-Debt Ratio of -0.38x as of December 2025, meaning its operating cash flow of $-3.24 Million could theoretically repay 0% of its total liabilities ($8.43 Million) in one year. See ALLR FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Allarity Therapeutics Inc Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Allarity Therapeutics Inc across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Allarity Therapeutics Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Allarity Therapeutics Inc (2015–2025)
Year-by-year debt coverage analysis for Allarity Therapeutics Inc. Check ALLR cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.76x | $-14.82 Million | $8.43 Million | ▼ -9.8% |
| 2024 | -1.60x | $-17.35 Million | $10.84 Million | ▼ -83.6% |
| 2023 | -0.87x | $-12.74 Million | $14.61 Million | ▲ +34.4% |
| 2022 | -1.33x | $-16.82 Million | $12.65 Million | ▼ -172.4% |
| 2021 | -0.49x | $-15.05 Million | $30.85 Million | ▲ +55.9% |
| 2020 | -1.11x | $-7.25 Million | $6.55 Million | ▼ -17.1% |
| 2019 | -0.94x | $-10.11 Million | $10.70 Million | ▼ -138.2% |
| 2018 | -0.40x | $-4.24 Million | $10.69 Million | ▲ +49.9% |
| 2017 | -0.79x | $-1.34 Million | $1.70 Million | ▲ +73.4% |
| 2016 | -2.98x | $-3.98 Million | $1.34 Million | ▲ +24.0% |
| 2015 | -3.92x | $-2.03 Million | $518.15K | — |